Evidence map›Paper›PMID 32617453›Full record

ArticleCurrent developments in nutrition2020

Multistrain Probiotic Increases the Gut Microbiota Diversity in Obese Pregnant Women: Results from a Randomized, Double-Blind Placebo-Controlled Study.

Sofie Ingdam Halkjær, Victoria Elizabeth de Knegt, Bobby Lo, Lisbeth Nilas, Dina Cortes, Anders Elm Pedersen, Hengameh Chloé Mirsepasi-Lauridsen, Lee O'Brien Andersen, Henrik Vedel Nielsen, Christen Rune Stensvold and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Current developments in nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02508844 (The POP-study), which is not on this map. Cited by 30 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 6 pooled it
2.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02508844 phase4completednot on this map

The POP-study: Effect of Probiotics on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn - a Randomized, Double-blind Placebo Controlled Trial With Vivomixx®

TypeinterventionalSponsorHvidovre University HospitalRan2015 to 2020Enrolled50ConditionsPregnancy, Obesity, Gestational Diabetes MellitusArmsVivomixx®, Placebo
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 6 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Maternal gut microbiota in the postpartum Period: A Systematic review.European journal of obstetrics, gynecology, and reproductive biology · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. A Review of Modulation of Gut Microbiota to Mitigate Gestational Diabetes: Implications for Maternal and Child Health.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Nutraceuticals in Pregnancy: A Special Focus on Probiotics.International journal of molecular sciences · 2024
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sofie Ingdam HalkjærGastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.ORCID 0000-0001-7518-4252
Victoria Elizabeth de KnegtDepartment of Pediatrics, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Bobby LoGastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Lisbeth NilasDepartment of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Dina CortesDepartment of Pediatrics, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Anders Elm PedersenDepartment of Dentistry, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hengameh Chloé Mirsepasi-LauridsenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Lee O'Brien AndersenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Henrik Vedel NielsenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Christen Rune StensvoldDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Thor Bech JohannesenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Thomas KallemoseClinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Karen Angeliki KrogfeltDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Andreas Munk PetersenGastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Statens Serum Institut · DKHvidovre Hospital · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaternal obesity is associated with adverse pregnancy outcomes. Probiotic supplementation during pregnancy may have positive effects on blood glucose, gestational weight gain (GWG), and the risk of gestational diabetes mellitus [GDM and glycated hemoglobin (HbA1c)].

objectivesThis feasibility study involved a daily probiotic intervention in obese pregnant women from the early second trimester until delivery. The primary aim was to investigate the effect on GWG and maternal glucose homeostasis (GDM and HbA1c). Secondary aims were the effect on infant birth weight, maternal gut microbiota, and other pregnancy outcomes.

methodsWe carried out a randomized double-blinded placebo-controlled study in 50 obese pregnant women. Participants were randomly allocated (1:1) to multistrain probiotic (4 capsules of Vivomixx

resultsForty-nine participants completed the study. Thirty-eight participants took >80% of the capsules (

conclusionsAdministration of probiotics during pregnancy is feasible in obese women and the women were willing to participate in additional study visits and collection of fecal samples during pregnancy. Multistrain probiotic can modulate the gut microbiota in obese women during pregnancy. A larger study population is needed to uncover pregnancy effects after probiotic supplementation. This trial was registered at clincaltrials.gov as NCT02508844.

Indexed as

gestational diabetes mellitusgestational weight gainmicrobiotaobesitypregnancyprobiotics

Identifiers

PMID32617453
PMCPMC7319727
OpenAlexW3031583801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.